📊 Evidence-Based Reference

philips intellivue mp5 patient monitor

Philips Medizin Systeme Boblingen

Summary: The Philips IntelliVue MP5 is a patient monitor designed for continuous monitoring of vital signs. It is primarily used in hospital settings to track patient status. Key evidence highlights issues with alarm fatigue and the potential for early warning scoring to prevent failure to rescue.

FDA Clearance Information

Pathway 510K
Decision Date November 24, 2008
Product Code MHX
Device Class Class 2
Evidence 419 studies

The Philips IntelliVue MP5 Patient Monitor was cleared by the FDA via the 510(k) pathway on November 24, 2008. It is manufactured by Philips Medizin Systeme Boblingen and is classified as a Class 2 device under the product code MHX.

What It Is

The Philips IntelliVue MP5 is a patient monitoring device that provides continuous surveillance of vital signs such as heart rate, blood pressure, and oxygen saturation. It is intended for use in various clinical settings to assist healthcare providers in monitoring patient status and making informed clinical decisions.

Clinical Applications

Commonly used in hospital environments, the Philips IntelliVue MP5 is employed in medical/surgical floors and other non-critical care areas to monitor patients' vital signs. It helps clinicians detect early signs of patient deterioration and manage patient care effectively.

Evidence Summary

The available literature includes two studies: one published in 2011 and another with an unknown publication date. These studies explore the impact of monitoring devices on alarm fatigue and the use of early warning scoring systems to prevent failure to rescue.

Reported Outcomes

Published studies report that the high frequency of false alarms from monitoring devices can lead to alarm fatigue, potentially impacting patient care. Another study suggests that early warning scoring systems may help in preventing failure to rescue, although specific outcomes were not detailed.

Safety Profile

Reported complications include alarm fatigue due to the high frequency of false or unnecessary alarms, which can desensitize staff and lead to missed critical alarms. No other specific safety data were provided in the studies.

Evidence Limitations

The evidence is limited by the small number of studies and lack of detailed outcomes and safety data. Further research is needed to quantify the impact of alarm fatigue and to evaluate the effectiveness of early warning scoring systems in diverse clinical settings.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Philips IntelliVue MP5?

The Philips IntelliVue MP5 is indicated for continuous monitoring of vital signs in hospital settings, particularly on medical/surgical floors.

What outcomes have been reported in clinical studies?

Studies highlight issues with alarm fatigue and suggest that early warning scoring may help prevent failure to rescue.

What complications have been reported?

Safety data indicate alarm fatigue as a complication due to frequent false alarms, potentially leading to missed critical alarms.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.